| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,185 |
10,870 |
$529K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,588 |
4,936 |
$198K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
856 |
781 |
$29K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
653 |
596 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
911 |
704 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
762 |
402 |
$7K |
| 80305 |
|
1,135 |
979 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
60 |
57 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
377 |
350 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
17 |
16 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
113 |
101 |
$837.05 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
127 |
114 |
$569.92 |
| 92551 |
|
75 |
69 |
$494.13 |
| 96127 |
|
101 |
95 |
$400.51 |
| 99173 |
|
74 |
68 |
$323.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
188 |
168 |
$58.61 |
| 81002 |
|
15 |
13 |
$10.49 |